ライフサイエンスコーパス: chart

1 0.54 +/- 0.18 (decimal fraction, Snellen eye chart).

2 sual acuity were assessed using a 3-m logMAR chart.

3 t least 2 lines on the Snellen visual acuity chart.

4 nged in a layout similar to the ETDRS acuity chart.

5 visual acuity was measured using the logMAR chart.

6 arithm of minimum angle of resolution visual chart.

7 15-letter change on the ETDRS visual acuity chart.

8 analysis of data, and interpretation of run charts.

9 measured quantitatively using M-charts and D-charts.

10 measured VA with standardized Radner reading charts.

11 5th percentile on the CDC BMI-for-age growth charts.

12 ncluding the selection of appropriate growth charts.

13 ht, weight, and BMI Z-scores CDC 2000 growth charts.

14 best-corrected or presenting VA from medical charts.

15 trol and Prevention (CDC) BMI-for-age growth charts.

16 WHO growth charts with that of other growth charts.

17 related adverse events were described with G charts.

18 uring follow-up, were collected from patient charts.

19 fter surgery using logarithmic visual acuity charts.

20 mes were ascertained from referral forms and charts.

21 ng 5-letter-per-line retroilluminated logMAR charts.

22 eed well with those of the ETDRS and Snellen charts.

23 boratory testing were collected from patient charts.

24 a limiting factor for generalization of the charts.

25 ed in the current CDC body mass index growth charts.

26 and HbA1c levels were retrieved from medical charts.

27 in all patients with an available electronic chart (36/96; 38%).

28 rs for Disease Control and Prevention growth charts), 46.9% were overweight, 36.4% had class I obesit

29 We evaluated 105 charts, 68 of which (64.8%) included SLAV data.

30 The measurements proposed here chart a course for pioneering exploration of the veiled

31 Given its generic ability to chart a functional RNA landscape irrespective of transcr

32 To chart a path for the future, this report analyzes the ch

33 rends in network neuroscience and attempt to chart a path toward a better understanding of the brain

34 employed by some countries can be helpful in charting a way forward.

35 Chart abstraction was performed on 204 patients (758 cou

36 d organism and site of sepsis through manual chart abstraction.

37 by a mean of less than 1 line on a standard chart after 5 to 12 weeks for children pretreated with g

38 A retrospective consecutive chart analysis was performed on 117 eyes from 117 patien

39 ted visual acuity using an automated Snellen chart and induction of astigmatism for eyes with at leas

40 The Pelli-Robson letter chart and the CSV-1000 test were used to estimate contra

41 ween the smartphone-based test and the ETDRS chart and the smartphone-based test and Snellen acuity d

42 ata; development of a coding scheme; coding, charting and cross comparison of data; interpretation of

43 ler grid and measured quantitatively using M-charts and D-charts.

44 Charts and imaging studies of highly myopic patients pre

45 ults are presented in a comprehensive set of charts and interactive alignment view.

46 Review of charts and photographs comprised best-corrected visual a

47 We measured VA with Radner reading charts and QoL with the Health Utilities Index issue 3 (

48 Radiation charts and simulation radiographs were used to estimate

49 Retrospective review of charts and slit-lamp images of 564 consecutive patients

50 Clinical charts and spectral-domain OCT images of 194 eyes of 172

51 In this institutional study, clinical charts and spectral-domain optical coherence tomography

52 Clinical charts and spectral-domain optical coherence tomography

53 treatment data were extracted from clinical charts and tabulated for analysis.

54 Data were tracked with annotated control charts and with interrupted time-series analysis.

55 Score, the Systemic Coronary Evaluation risk chart, and the modified American College of Cardiology/A

56 rs for Disease Control and Prevention growth charts, approximately 17% of children and adolescents ag

57 Horizon Charts are a relatively new visualization method that, u

58 However, existing charts are few in number, were based on small sample siz

59 There is no consensus with regard to which charts are most suitable for monitoring the postnatal gr

60 We used novel transceiver technology to chart association patterns across 19 days in a wild popu

61 o 2.1-fold when compared to information from chart audits.

62 then assessed by an examiner with a standard chart-based near ETDRS acuity test before the MAVERIC-C

63 We were unable to fully customise centile charts because we lacked data on maternal weight and eth

64 , the recommended method is the ETDRS letter chart, because letter acuity is more predictive for func

65 documented visual acuity on the Snellen eye chart before the injection ranged from 20/30 to 20/200.

66 on a Receiver Operating Characteristic (ROC) chart, beginning with an over-motivated state with many

67 genetic and epigenetic differences have been charted between normal and breast cancer tissues, change

68 ntal orientations that underpin family life; chart brain-hormone-behavior constellations for the matu

69 Horizon Charts can be an effective visual tool to explore comple

70 ented population-based pregnancy weight-gain charts can be used to express maternal weight gain as ge

71 um nanoparticles incorporated volumetric bar-chart chip (PtNPs-V-Chip) is able to be used for point-o

72 Visual acuity (Snellen chart), color vision (Ishihara pseudoisochromatic plates

73 ity, clinical evaluation (slit lamp), Amsler chart, color fundus photographs, infrared reflectance, r

74 The 24-hour frequency and volume chart data included the nocturia index (nocturnal urine

75 Sociodemographic and clinical chart data were abstracted from all medication abortion

76 for Disease Control and Prevention's growth chart data were used to calculate age- and sex-specific

77 Using methods that combine chart data, including electronic medical records (EMR),

78 ing and microbiology data were compared with chart data.

79 Proportion charts described processes over time (2 monthly interval

80 (i) provide an overview of the impact of the chart design on near visual acuity measured, and (ii) de

81 Chart design, viewing distance, and threshold choice hav

82 Charting differences between tumors and normal tissue is

83 bolus, pneumonia, and death when compared to chart documentation alone.

84 ng visual acuity was measured using a logMAR chart during an ophthalmic examination at baseline and f

85 n factors, with parallel RNA sequencing, has charted epigenetic regulation of gene expression by proi

86 n Early Treatment Diabetic Retinopathy Study charts (ETDRS), on the retina of her left eye white, pro

87 Traditional graphs and charts failed to convey the complex shapes of brain stru

88 Each chart flagged during the initial screen was then manuall

89 ne the significance of each factor by Pareto chart followed by optimization of these significant fact

90 agreement of MAVERIC-C score with near ETDRS chart for visual acuity.

91 ication and retrospectively analyzed medical charts for 115 patients with CLCNKB mutations.

92 Automated algorithms generated charts for 12 months of sequential data.

93 sed measurements, and the corresponding risk charts for 182 countries to predict 10-year risk of fata

94 ms (EICs), absolute and relative stacked bar charts for all isotopologues, and a .csv data file.

95 We reviewed the predonation charts for all living kidney donors in Ontario, Canada b

96 formance compared with other existing growth charts for early detection of target conditions.

97 This study provides WHO fetal growth charts for EFW and common ultrasound biometric measureme

98 priority to provide the present fetal growth charts for estimated fetal weight (EFW) and common ultra

99 We reviewed the medical charts for patients as described above.

100 es used to develop existing postnatal growth charts for preterm infants and their methodologic qualit

101 but intrauterine body composition reference charts for preterm infants are lacking.

102 y objective the creation of postnatal growth charts for preterm infants, was conducted.

103 ancy weight-gain-for-gestational-age z score charts for Swedish women who were stratified by early pr

104 ipt library (Cubism) that implements Horizon Charts for the time series domain so that it works effec

105 ese are the first body composition reference charts for total FM and FFM at birth in preterm infants

106 A score chart, for routine clinical use, was derived from the pr

107 results are shown in interactive JavaScript chart framework using DC.js.

108 SETTING/A sample of 183 charts from 584 inpatients involved in over 600 RRT even

109 We evaluated clinic charts from 821 AL patients seen at the Mayo Clinic who

110 lication of genetic knockout approaches will chart functional landscapes of receptors and endocytic p

111 We accurately predict current densities and chart functional redundancy.

112 Review of clinical charts, fundus drawings, Ret-Cam 3 images, and histopath

113 catalog RiPP biosynthetic gene clusters and chart genetically encoded RiPP chemical space.

114 Two studies reported that WHO growth charts had poorer performance compared with other existi

115 A look up chart has been provided for investigators who would like

116 Horizon Charts have been successfully applied to understand mult

117 Pregnancy weight-gain z score charts have recently been proposed as a new tool for cla

118 A total of 58 patient charts having at least 1 fetal MRI were reviewed.

119 hickness profile scale in 46% and in the pie chart in 21%.

120 Based on review of the insulin/glucose chart in the electronic medical record, recommendations

121 Here, we charted in detail the structural microheterogeneity of C

122 d trafficking requires detailed navigational charts in the form of their three-dimensional structures

123 Data were collected from patient charts including gender, gestational age at birth, birth

124 Data were collected from patient charts, including gender, date of birth, gestational age

125 te analysis, abundance-based heatmaps, and a chart indicating the geographic distribution of each sam

126 n Early Treatment Diabetic Retinopathy Study charts, injection episodes, and complications were recor

127 ission n = 59) were identified based on Life Chart Interview measuring the presence of symptoms each

128 Aging Chart is a new, community-curated collection of aging pa

129 er-defined scheme, which is displayed as pie-chart like graphs embedded into the network.

130 in uveitic eyes (5 letters = 1 visual acuity chart line; potential range of change in letters read, -

131 Here we chart liver metabolic activity and functionality in NAFL

132 AR visual acuity scores for each test: ETDRS chart logMAR, Snellen acuity, and Peek Acuity.

133 Growth charting methods are widely used to assess the developme

134 Review of clinical charts, multimodal imaging, electrophysiologic findings,

135 A flow chart of the compilation process with standard operating

136 of cell types, paving the way for systematic charting of cell atlases.

137 f kinase consensus substrates that allow the charting of cellular phosphorylation events (often calle

138 This type of charting of specific CID reaction pathways can offer val

139 lecular characterisation of PPIs implies the charting of their interfaces, that is, the surfaces medi

140 We reviewed charts of 158 patients who met diagnostic criteria for o

141 The charts of 212 patients (338 eyes) with HLA-B27-associate

142 Charts of 55 patients and 134 implants were included.

143 The charts of all patients receiving a solid organ transplan

144 We reviewed the charts of consecutive patients with optic neuropathies c

145 The charts of deceased patients were reviewed for liver biop

146 ical controls identified out of 6867 medical charts of HSCT patients by blinded independent reviewers

147 Complete charts of patients >/=18 years old with one or more dent

148 A retrospective study based on the hospital charts of patients discharged with a diagnosis of pancre

149 The charts of patients with idiopathic noncirrhotic portal h

150 Review of the medical charts of patients with noninfectious scleritis refracto

151 The charts of patients with ocular syphilis (regardless of h

152 Charts of size at birth are used to assess the postnatal

153 Prenatal charts of women enrolled in the WHEALS birth cohort were

154 ed visual acuity (BCVA) measurement on ETDRS chart, optical coherence tomography (OCT), and fluoresce

155 ass index (BMI) that does not require growth charts or percentiles.

156 ing studies, is often graphed as stacked bar charts or pie graphs that use color to represent taxa.

157 , and in other technologies are vast, and we chart out some possibilities.

158 Here we chart out the Fluc pore and characterize its chemical re

159 iologic features were extracted from medical charts over a mean follow-up of 9 years.

160 In an attempt to chart parallel sensory streams passing through the visua

161 nformation capture technologies (e.g., Hi-C) chart physical interactions between chromatin regions on

162 10 largest print sizes on the MNREAD Acuity Chart (Precision Vision) (0.4-1.3 logarithm of the minim

163 ies, assessment of outliers, covariates, and chart presentation.

164 Age- and sex-specific growth charts produced by the Centers for Disease Control and P

165 INTERPRETATION: Our risk charts provide risk assessment tools that are recalibrat

166 the two-digit resolution of panel meters and chart recorders and then took the first steps into autom

167 tment Diabetic Retinopathy Study (ETDRS) eye chart remained unchanged from baseline to 3 months in th

168 on fundus autofluorescence was included for chart review and examination of multimodal imaging (stud

169 Data were collected by chart review and included patient demographics, clinical

170 Clinical chart review and multimodal imaging established the SHRM

171 fected and 152 HEU participants) by means of chart review and self-report at 13 sites.

172 Retrospective chart review between December 1990 and June 2014.

173 tric Health Information System database, and chart review confirmed eligibility, treatment assignment

174 were studied retrospectively by standardized chart review data.

175 Chart review did not find significant differences betwee

176 Outcomes from chart review encompassed initial postdeployment clinical

177 Chart review for 12 AEs for patients enrolled in AAML053

178 Retrospective cohort study with chart review for inpatient quality metrics, 30 day morta

179 tes were compared to patient-level data from chart review from two large OPOs.

180 A retrospective chart review in 9 MS centres was performed in order to i

181 s nonsyndromic) was done via blinded medical chart review in mGluR positive and randomly selected mGl

182 Retrospective chart review included medical records of all patients di

183 Retrospective chart review indicated that most isolates were clinicall

184 Retrospective chart review of 1,157 medical ICU admissions from March

185 We performed a retrospective chart review of 11 patients with DOCK8 deficiency and me

186 A retrospective chart review of 4 patients diagnosed with late subconjun

187 Photographic and chart review of acute ocular findings, interventions rec

188 A chart review of all patients presenting with full-thickn

189 Chart review of cohorts A (n = 511) and B (n = 127) demo

190 ssed by determining both criterion validity (chart review of EMRs by abstractor as a gold standard) a

191 A 13-year retrospective chart review of Group D eyes treated initially with intr

192 Retrospective chart review of HIV-infected patients enrolled in a larg

193 We performed a multicenter, retrospective chart review of laboratory-confirmed cases of emmonsiosi

194 aluation were analyzed using a retrospective chart review of patients first seen between October 1, 2

195 A retrospective chart review of patients less than 15 years of age who u

196 We conducted a retrospective chart review of patients who had undergone evisceration

197 A retrospective chart review of rapid response calls made in 2015 was us

198 r support attributes through a retrospective chart review of social workers' psychosocial assessments

199 Chart review of these patients was performed to confirm

200 management was also obtained via electronic chart review or patient contact (n = 45).

201 tio = 1.70 [95% CI: 1.06, 2.71], P = .0202), chart review showed that no death was attributable to AK

202 nal review board approved this retrospective chart review study and waived the requirement to obtain

203 A multicenter, retrospective, open-label chart review study investigated the efficacy and safety

204 This is a retrospective chart review study.

205 Medical chart review suggested that most of these later-growing

206 m for asthma criteria to enable an automated chart review using electronic medical records (EMRs).

207 A comprehensive chart review was conducted on 25 patients (28 eyes) iden

208 te the Q3 responses, a systematic electronic chart review was conducted.

209 Chart review was done of consecutive patients who underw

210 A chart review was performed jointly by a strabismus speci

211 Chart review was performed on 664 patients followed from

212 A retrospective chart review was performed on patients at Children's Hos

213 Chart review was the criterion standard for validating t

214 A chart review yielded demographics, clinical information,

215 who actually received the process (based on chart review) and who were classified correctly by the E

216 not eligible to receive a process (based on chart review) and who were correctly identified as not e

217 taff interviews, shift coupons, observation, chart review, and accident or incident reports.

218 The clinical research ethics board approved chart review, and the requirement to obtain informed con

219 des were deemed clinically significant after chart review, indicating that in the majority of cases (

220 Recipient chart review, using a case (DENV positive)-control (DENV

221 criteria applied to data collected by manual chart review.

222 U/mL) requiring treatment were identified by chart review.

223 Data were ascertained by standardized chart review.

224 visits, and prescribed opioid dose based on chart review.

225 dherence to AASLD guidelines was assessed by chart review.

226 tics were collected by interview and medical chart review.

227 iasis Observational Procedure: Retrospective chart review.

228 indeterminate diagnoses removed by means of chart review.

229 n 1 year were collected retrospectively from chart review.

230 A multicenter retrospective (2001-2015) chart review.

231 Retrospective chart review.

232 Data was gathered via retrospective chart review.

233 h 691.8 and 692.9 were randomly selected for chart review.

234 he intensive care unit using a retrospective chart review.

235 ective observational study and retrospective chart review.

236 y, the Dutch Pathology Registry, and medical chart review.

237 eyes (46.5%) were diagnosed with glaucoma by chart review; 41.2%-59.0% of eyes were remotely diagnose

238 ether they sought HIV care, verified through chart reviews at 23 local clinics.

239 Manual chart reviews confirmed a true absence of follow-up in 7

240 iter positive CrAg LFA results, we performed chart reviews for all patients with positive CrAg LFA re

241 Patient chart reviews of discrepant results suggested that the L

242 Chart reviews showed that the percentage of adult patien

243 ilized site-specific laboratory criteria and chart reviews to identify species within the diphtheroid

244 Patient interviews and medical chart reviews were conducted on 10 men who became ill fo

245 Retrospective chart reviews were used in one study.

246 Semiannual visits included questionnaires, chart reviews, cervical/anal cytologic and cervical/anal

247 unit transfusions from systematic individual chart reviews.

248 est(s), vision assessment(s), visual acuity, chart(s) and near.

249 ected from clinical notes using the WHO Life Chart Schedule.

250 Francisco, California, who underwent visual chart screening during the 2009-2012 academic years and

251 d seventy-five children who underwent visual chart screening were referred for community-based compre

252 Comparison with the near EDTRS chart showed agreement with a mean difference of -0.0879

253 Event charts showed earlier occurrences of higher grades of di

254 ent were extracted from the digital hospital chart system.

255 Detailed history, pedigree charting, systemic and ocular examination of 10 eyes (5

256 We chart the development of man-made transmembrane systems;

257 of specific drug intermediates and APIs, we chart the development of omega-TAms using protein engine

258 Here, we used genetic fate mapping to chart the embryological origins of the tissues in the mo

259 h the development of protocols to direct and chart the fate of differentiated neurons.

260 of epistatic interactions and have begun to chart the fitness landscapes in protein sequence space.

261 As the new US administration and Congress chart the future of health and health care for the Unite

262 he major challenge for the next decade is to chart the many cellular processes that underlie this pha

263 These findings chart the pathway of FABP4 secretion and provide a poten

264 ing individuals is fundamental in efforts to chart the relation between human behavior, health and di

265 To chart the structural variation observed in IMMS, the col

266 ent diagnosis of Parkinson's disease, and to chart the timeline of these first presentations before d

267 s the feasibility of large-scale analyses to chart the transcriptome in situ in human cancers and the

268 rlap of experiments and theory, ranging from charting the design metrics useful for developing the ne

269 d comment on the utility of animal models in charting the developmental progression and interaction o

270 The field would be greatly served by charting the process of data harmonization to enhance th

271 Charting the reasoning staff provided for technique sele

272 e an evolutionary history for this receptor, charting the structural and cellular changes that took p

273 Charting the uplift history is crucial for understanding

274 This study charts the growth of the drug delivery literature publis

275 This article charts the rise and fall of the IEGs and explores the pa

276 This review charts the rise of USA300 and the evidence that suggests

277 From these charts, the following data were recorded: 1) age; 2) sex

278 incentives for practices to review patients' charts to assess appropriateness.

279 ble AERD." Two clinical experts reviewed all charts to confirm a diagnosis of "clinical AERD" and cla

280 Retrospective review of the database and charts to identify all patients treated for ROP milder t

281 nce to support the use of customised centile charts to identify those at risk of stillbirth and infan

282 opular plugin, the 'Gene expression/activity chart', to include approximately 6000 datasets (from app

283 Viewing distance, chart used, and letter spacing should be adapted to the

284 Our dichoptic letter chart was composed of band-pass filtered letters arrange

285 Each patient's medical chart was reviewed by two independent investigators who

286 A retrospective analysis of 384 charts was completed from three periodontal practices ac

287 Through systematic inspection of individual charts, we identified primary and secondary diagnoses, v

288 Medical charts were abstracted for hospitalized UC.

289 Among enrolled patients whose medical charts were available for review post-discharge, 61 (27%

290 Pedigree charts were constructed for 829 individuals, including 1

291 Patient charts were reviewed focusing on level-of-care and comor

292 Patients' charts were reviewed for demographic data, clinical pres

293 Charts were reviewed for demographic data; transplant da

294 her exposures and characteristics, and their charts were reviewed for the Extremely Low Gestational A

295 Charts were reviewed retrospectively.

296 Patient charts were reviewed to determine the incidence of posit

297 patients were interviewed and their medical charts were reviewed using a pretested structured questi

298 112 resident and 100 faculty charts were reviewed.

299 Charts with search terms for asthma, nasal polyps, and r

300 comparing the performance of new WHO growth charts with that of other growth charts.